Biocartis

Biocartis is an innovative commercial-stage molecular testing company committed to revolutionizing molecular testing through its unique proprietary Idylla™ platform. We provide next-generation testing solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers, and the healthcare industry, with a primary focus on oncology. Our proprietary Idylla™ platform is a fully automated real-time system that delivers highly reliable molecular information from tissue and plasma in almost any laboratory setting. This is the world's first fully automated molecular testing system, with an expanding menu primarily focused on oncology.